ArticleBiosensors2022

Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis.

Rokhsareh Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.